Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV

Cell Mol Immunol. 2020 May;17(5):536-538. doi: 10.1038/s41423-020-0385-z. Epub 2020 Mar 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Viral
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Epitopes
  • Glycoproteins
  • Humans
  • Pandemics
  • Pneumonia, Viral
  • SARS Virus*
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus

Substances

  • Antibodies, Viral
  • Epitopes
  • Glycoproteins
  • Spike Glycoprotein, Coronavirus